Cargando…
Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
Lesch-Nyhan syndrome (LNS) is inherited as an X-linked recessive genetic disorder caused by mutations in hypoxanthine-guanine phosphoribosyl transferase 1 (HPRT1). Patients with LNS show various clinical phenotypes, including hyperuricemia, gout, devastating behavioral abnormality, intellectual disa...
Autores principales: | Jang, Gayoung, Shin, Ha Rim, Do, Hyo-Sang, Kweon, Jiyeon, Hwang, Soojin, Kim, Soyoung, Heo, Sun Hee, Kim, Yongsub, Lee, Beom Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996127/ https://www.ncbi.nlm.nih.gov/pubmed/36910714 http://dx.doi.org/10.1016/j.omtn.2023.02.009 |
Ejemplares similares
-
CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
por: Jang, Gayoung, et al.
Publicado: (2023) -
Dopamine function in Lesch-Nyhan disease.
por: Nyhan, W L
Publicado: (2000) -
Attenuated variants of Lesch-Nyhan disease
por: Jinnah, H. A., et al.
Publicado: (2010) -
Lesch-Nyhan Syndrome in an Indian Child
por: Chandekar, Priyanka, et al.
Publicado: (2015) -
Lesch–Nyhan syndrome: a case report
por: Park, Han Ick, et al.
Publicado: (2023)